Phase 3
Completed N=61
Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda
Post Operative Pain · Postoperative Pain
Source: ClinicalTrials.gov NCT02514122 ↗
Enrolled (actual)
61
Serious AEs
0.0%
Results posted
Nov 2018
Primary outcomePrimary: Postoperative Pain as Measured on a 11-point Numerical Rating Scale — 3.5; 4.9 units on a scale — p=0.009
◆ Published Evidence
Emerging
7citations · ~1 / year
Subcutaneous ketamine for postoperative pain relief in Rwanda: a randomized clinical trial.
Summary
A randomized double blind control trial to investigate the safety and efficacy of subcutaneous ketamine for control of post operative pain in low resource settings.
Linked Publications
-
Subcutaneous ketamine for postoperative pain relief in Rwanda: a randomized clinical trial.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Postoperative Pain as Measured on a 11-point Numerical Rating Scale |
3.5; 4.9 | 0.009 sig |
| SECONDARY Hallucination |
11; 0; 19; 29 | <0.001 sig |
Eligibility Criteria
Inclusion Criteria
- All patients undergoing upper abdominal, thoracic, gynecologic or orthopaedic surgeries during a one month period with expected post operative hospital admission
Exclusion Criteria
- Allergy to Ketamine
- History of narcotic abuse or dependence
- Those patients for which decreased cognitive function is a barrier to accurate data collection
Data sourced from ClinicalTrials.gov (NCT02514122) and the linked publication. Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.